Health experts are divided over whether it’s wise for the FDA to move ahead with approving a two-dose plan for kids on its own rather than waiting for data on the third dose.
during the Omicron wave. Relative to the minor risks of the vaccine itself, experts say the potential benefits — which also include relief for worried parents and fewer COVID-related childcare disruptions — make speeding up the approval process worthwhile.Critics, however, worry about the risks of approving a vaccine without solid evidence that it will provide the necessary amount of immunity. It would be better, they argue, to wait until there’s complete data on all three doses, which.
. Critics of the FDA’s strategy worry that headlines about approval of an unproven vaccine might make the problem worse.The FDA’s vaccine advisory committee is scheduled to meet next week to discuss whether to recommend approving Pfizer’s two-dose vaccine, with a final decision expected before the end of the month.
“Covid vaccine efficacy is not a binary ‘works’ or ‘doesn’t work’ — it’s looking more like an ascending scale of protection” — Jessica Grose,“Vaccinating our children won’t end the pandemic. There are still too many people choosing to forgo the jab. New variants are to be expected. But as a COVID doctor and as a mother, at least one more demographic of society, arguably our most precious, will no longer be left to fend for themselves.
“People latched on to the idea that an ineffective two-dose vaccine might be authorized. … The way the information on potential pediatric vaccine authorization has been rolled out is a problem — it has led to confusion, uncertainty, concern about integrity of the process. — Walid Gellad, health policy expert, to“I think already it’s kind of a disaster for vaccine uptake in kids. … Is it throwing gasoline on a dumpster fire? Maybe. But it was already a dumpster fire.
Is there a topic you’d like to see covered in “The 360”? Send your suggestions to [email protected].
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Addressing Ongoing COVID-19 Vaccine Questions With CDC and FDA ExpertsJoin COVIDVxProject on 2/10 at 11:30 am ET for an informative webinar addressing COVID19 vaccine questions. Hear directly from the CDCDirector, FDACBER's Dr. Peter Marks, and CDCgov’s Dr. Sara Oliver. RSVP to secure your spot.
Les mer »
COVID test recall 2022: Which at-home tests does FDA recommend using?At-home COVID-19 tests are a key part of America's pandemic response but the FDA urges people to only use authorized tests to avoid false negatives.
Les mer »
US preps 10 million doses of COVID-19 vaccine for kids under 5, pending FDA authorizationCOVID-19 vaccines for kids under 5 have not yet been authorized, but the rollout plan is already in the works.
Les mer »
Utah’s COVID long-haulers are predominantly young — and many were previously healthy, doctors say“Honestly, we have seen a lot of patients that really had no medical history prior to this that they could really speak of,” said Dr. Jeanette Brown, a pulmonologist and medical director of the U.’s COVID-19 Long Hauler Clinic.
Les mer »
1 Arrested In Robbery Of Two Young Teen Girls In Fairfax DistrictDetectives have arrested one juvenile allegedly responsible for the robbery of two teenage girls walking to school in the Fairfax District.
Les mer »
US plans to roll out initial 10 million Covid-19 vaccine doses for children under 5 after FDA authorization, CDC document saysIf the Pfizer/BioNTech coronavirus vaccine receives emergency use authorization from the US Food and Drug Administration for children 6 months to 5 years old, the tentative plan is to roll out about 10 million vaccine doses initially, according to a US Centers for Disease Control and Prevention document posted online.
Les mer »